Barbara H. Johnson, MBA

Medication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.